Active Research Protocols
- 00-C-0092 – A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy
- 08-C-0080 – SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas
- 09-C-0054 – A Group Wide Biology and Banking Study for Phase II Study of R1507
- 11-C-0113 – A Pilot Study of Genetically Engineered NY-ESO-1 Specific (c259) T cells in HLA-A2+ Patients with Synovial Sarcoma
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014